Workflow
加速构建脑机接口 “热带雨林式”创新生态
Zheng Quan Ri Bao·2025-08-09 01:23

Core Viewpoint - The recent implementation of the "Implementation Opinions on Promoting the Innovation and Development of the Brain-Computer Interface Industry" by seven departments, including the Ministry of Industry and Information Technology, aims to achieve breakthroughs in key technologies by 2027 and establish an advanced technological, industrial, and standard system for the brain-computer interface industry [1] Group 1: Industry Development - The brain-computer interface industry is currently in its early development stage in China, necessitating the cultivation of leading enterprises with strong resource integration and technological capabilities [1] - The establishment of a "tropical rainforest" innovation ecosystem is essential, comprising leading enterprises ("tall trees") and innovative SMEs ("bushes") to foster a multi-layered, symbiotic environment [1][2] Group 2: Technological Advancements - Notable advancements include the semi-invasive "Beijing Brain No. 1" and invasive "Beijing Brain No. 2" intelligent brain-computer systems developed by the Beijing Brain Science and Brain-like Research Institute in collaboration with Beijing Chip Intelligence Technology Co., Ltd., both achieving world-leading levels [2] - The first prospective clinical trial of an invasive brain-computer interface system in China was successfully completed in March 2025, marking a significant milestone in the field [2] Group 3: Policy and Capital Support - A series of supportive policies have been introduced at both national and local levels to create a favorable environment for the brain-computer interface industry, including measures for the approval of medical devices based on brain-computer interface technology [3] - The National Medical Insurance Administration has initiated a pricing project specifically for new brain-computer interface technologies, facilitating their entry into clinical applications [3] - Significant capital interest is evident, with Shanghai Ladder Medical Technology Co., Ltd. completing a record-breaking 350 million yuan Series B financing round in February, indicating growing investment in the sector [3]